A detailed history of Centiva Capital, LP transactions in Nevro Corp stock. As of the latest transaction made, Centiva Capital, LP holds 23,462 shares of NVRO stock, worth $93,144. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,462
Previous 43,525 46.1%
Holding current value
$93,144
Previous $366,000 64.48%
% of portfolio
0.0%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.71 - $10.1 $94,496 - $202,636
-20,063 Reduced 46.1%
23,462 $130,000
Q2 2024

Aug 14, 2024

BUY
$7.96 - $13.59 $242,700 - $414,359
30,490 Added 233.91%
43,525 $366,000
Q1 2024

May 15, 2024

BUY
$13.56 - $20.78 $176,754 - $270,867
13,035 New
13,035 $188,000
Q3 2023

Nov 14, 2023

BUY
$18.22 - $25.85 $246,225 - $349,336
13,514 New
13,514 $259,000
Q4 2020

Feb 16, 2021

SELL
$138.17 - $184.34 $365,459 - $487,579
-2,645 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$114.09 - $145.51 $301,768 - $384,873
2,645 New
2,645 $368,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $140M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.